Session Details

U015 Don’t Get VEXed: Demystifying VEXAS for the Dermatologist

Fri, Mar 27, 7:30 AM - 8:30 AM
Bluebird 2A
1 CME Available Focus Session NEW Upcoming
View Map

DESCRIPTION

VEXAS syndrome is a recently identified autoinflammatory disorder caused by somatic mutations in UBA1, leading to systemic inflammation, hematologic abnormalities, and characteristic dermatologic findings such as neutrophilic dermatoses and vasculitis. This session will provide an in-depth review of VEXAS syndrome with a focus on dermatologic manifestations, diagnostic strategies, and emerging treatment options. Through case-based discussions, attendees will gain insights into recognizing and managing this complex syndrome in dermatology practice.

LEARNING OBJECTIVES

1.

Recognize the cutaneous and systemic manifestations of VEXAS syndrome.

2.

Summarize diagnostic findings, including genetic testing and hematologic markers.

3.

Evaluate current and emerging treatment strategies for VEXAS syndrome.

SCHEDULE

7:30 AM

Don’t Get VEXed: Demystifying VEXAS for the Dermatologist

DIRECTOR

Sweta Subhadarshani, MD, MBBS, FAAD

Sweta Subhadarshani, MD, MBBS, FAAD

SPEAKERS

Urmi Khanna, MD, FAAD

Urmi Khanna, MD, FAAD

Lauren Michelle Madigan, MD, FAAD

Lauren Michelle Madigan, MD, FAAD

DISCLOSURES

Urmi Khanna, MD, FAAD

No financial relationships exist with ineligible companies.

Lauren Michelle Madigan, MD, FAAD

Blueprint Medicines – Advisory Board(Honoraria);

Sweta Subhadarshani, MD, MBBS, FAAD

No financial relationships exist with ineligible companies.